REVIEW OF INTRAVITREAL IMPLANTS FOR EXTENDED DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HAGHJOU N.; SOHEILIAN M.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2011 | Volume:16 | Issue:4 (65) Page(s): 351-359

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

978

Download:

Cites:

Information Journal Paper

Title

REVIEW OF INTRAVITREAL IMPLANTS FOR EXTENDED DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE

Author(s)

HAGHJOU N. | SOHEILIAN M. | Issue Writer Certificate

Keywords

INTRAVITREAL IMPLANTSQ3

DRUG DELIVERY SYSTEMQ3

SUSTAINED-RELEASEQ3

Abstract

Intravitreal injection is the most common approach for drug delivery to the posterior segment in humans.However, following the injection, drugs are rapidly eliminated from the vitreous, with half-lives up to a few days. Depending on the rate of clearance from the vitreous, large boluses and frequent administrations may be required to ensure therapeutic levels over an extended period of time. Multiple intraocular injections can lead to an increased likelihood of complications, such as vitreous hemorrhage, retinal detachment, endophthalmitis and cataract. In order to decrease the occurrence of complications associated with intravitreal injections, SUSTAINED-RELEASE DRUG DELIVERY SYSTEMs are desired to provide drug release into the posterior segment for a longer period of time (months or even years) compared to direct injection. This article reviews the current status of various INTRAVITREAL IMPLANTS, both approved and in clinical development. These implants are: Vitraset, Retisert, Ozurdex (Posurdex), I-vation, Iluvien (Medidur) and NT-501. A search of the English language PubMed database was conducted with keywords of “intraocular implant”, “intravitreal implant”, “sustained-release” and “intravitreal drug delivery”.

Cites

No record.

References

No record.

Cite

APA: Copy

HAGHJOU, N., & SOHEILIAN, M.. (2011). REVIEW OF INTRAVITREAL IMPLANTS FOR EXTENDED DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE. BINA, 16(4 (65)), 351-359. SID. https://sid.ir/paper/42920/en

Vancouver: Copy

HAGHJOU N., SOHEILIAN M.. REVIEW OF INTRAVITREAL IMPLANTS FOR EXTENDED DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE. BINA[Internet]. 2011;16(4 (65)):351-359. Available from: https://sid.ir/paper/42920/en

IEEE: Copy

N. HAGHJOU, and M. SOHEILIAN, “REVIEW OF INTRAVITREAL IMPLANTS FOR EXTENDED DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE,” BINA, vol. 16, no. 4 (65), pp. 351–359, 2011, [Online]. Available: https://sid.ir/paper/42920/en

Related Journal Papers